• ‘Should’ vs. ‘Should Not’ as an IPF Patient
  • Esbriet and Ofev Improve Pulmonary Fibrosis Lung Function, but Not N-acetylcysteine, Study Suggests
  • New Knowledge About Ofev and Esbriet May Lead to Better Lung Fibrosis Therapies
  • Patient Advocacy: A Privilege or a Curse?
  • First Patient Enrolled in Trial of Ofev for Progressive Fibrosing Interstitial Lung Disease
  • IPF Patients on Esbriet Live Approximately 2.5 Years Longer Than Untreated Patients, Study Finds
  • The Day I Found Out I Needed Supplemental Oxygen
  • How Do You Counter Feelings of Helplessness?
  • LOXL2 Protein Helps Promote Lung Scarring, Study Shows
  • Pulmonary Fibrosis Foundation Publishes Updated PF Information Guide
  • Restraining Myself from Participating in Extra Activities
  • Actors Gather in New York for PF Fundraising Event: ‘Broadway Belts for PFF!’